Abstract
ER resident glycoproteins, including
ectopically expressed recombinant glycoproteins,
carry so-called high-mannose type N-glycans, which
can be at different stages of processing. The presence
of heterogeneous high-mannose type glycans on
ER-retained therapeutic proteins is undesirable for
specific therapeutic applications. Previously, we
described an Arabidopsis alg3-2 glycosylation mutant
in which aberrant Man5GlcNAc2 mannose type N-glycans
are transferred to proteins. Here we show that the
alg3-2 mutation reduces the N-glycan heterogeneity on
ER resident glycoproteins in seeds. We compared the
properties of a scFv-Fc, with a KDEL ER retention tag
(MBP10) that was expressed in seeds of wild type and
alg3-2 plants. N-glycans on these antibodies from
mutant seeds were predominantly of the intermediate
Man5GlcNAc2 compared to Man8GlcNAc2 and
Man7GlcNAc2 isoforms on MBP10 from wild-type
seeds. The presence of aberrant N-glycans on MBP10
did not seem to affectMBP10 dimerisation nor binding
of MBP10 to its antigen. In alg3-2 the fraction of
underglycosylated MBP10 protein forms was higher
than in wild type. Interestingly, the expression of
MBP10 resulted also in underglycosylation of other,
endogenous glycoproteins.
Original language | English |
---|---|
Pages (from-to) | 1033-1042 |
Number of pages | 10 |
Journal | Transgenic Research |
Volume | 20 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2011 |